Syngene offers integrated and standalone services across the drug discovery continuum from Target Identification to IND enabling.

Syngene’s offers an end-to-end platform to deliver integrated and standalone services for small molecules across the Development continuum.

Syngene’s Target Identification and Validation services combine data, informatics, and knowledge about biological target assays for holistic target assessment and risk mitigation in drug discovery.

Syngene, with its comprehensive suite of DMPK profiling assays, can help you achieve a high rate of success with your clinical candidates across drug modalities.

Syngene’s Chemistry process research lab acts as a bridge between drug discovery and development when faster delivery of chemical compounds is required – mg to kg.

Syngene  has full value-chain Process Research and Development (PRD) capabilities for NCEs and advanced intermediates.

Syngene supports both developmentand manufacturing of Drug Products from early to late stage